Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Search for other papers by Liliana Ribeiro Santos in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Search for other papers by Inês Vasconcelos Bessa in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Public Health Unit, ACES Baixo Mondego, Coimbra, Portugal
Search for other papers by Adriana Gaspar da Rocha in
Google Scholar
PubMed
Department of Endocrinology, Hospital University Centre of São João, Porto, Portugal
Search for other papers by Celestino Neves in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Introduction Autoimmune thyroid disease (AITD) is one of the most prevalent groups of autoimmune diseases ( 1 ). Hashimoto’s thyroiditis (HT) and Graves' disease (GD) are the most significant AITDs ( 2 ), GD being around ten times less common
Search for other papers by Toshihide Yamamoto in
Google Scholar
PubMed
Introduction Variable occurrence of autoimmune thyroid disease (ATD) in patients with primary adrenal insufficiency (PAI) has been reported: 24% of 148 patients with Addison's disease in Poland [ 1 ], 47% of 664 patients in Norway [ 2 ], and
Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed
Search for other papers by John E.M. Midgley in
Google Scholar
PubMed
Search for other papers by Rolf Larisch in
Google Scholar
PubMed
Ruhr Center for Rare Diseases (CeSER), Ruhr University of Bochum and Witten/Herdecke University, Bochum, Germany
Search for other papers by Johannes W. Dietrich in
Google Scholar
PubMed
controls (n = 271), who showed no clinical evidence of the presence of thyroid dysfunction based on patient history, symptoms, physical examination, antibody status, and thyroid imaging, and (2) untreated patients with thyroid autoimmune disease (n = 86
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Cristina Dalmiglio in
Google Scholar
PubMed
Search for other papers by Nicoletta Benenati in
Google Scholar
PubMed
Search for other papers by Michele Campanile in
Google Scholar
PubMed
Search for other papers by Tania Pilli in
Google Scholar
PubMed
Search for other papers by Raffaella Forleo in
Google Scholar
PubMed
Search for other papers by Lucia Brilli in
Google Scholar
PubMed
Search for other papers by Cristina Ciuoli in
Google Scholar
PubMed
Search for other papers by Silvia Cantara in
Google Scholar
PubMed
Search for other papers by Marco Capezzone in
Google Scholar
PubMed
Search for other papers by Alessandra Cartocci in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
cytological and histological series. Conclusion Thyroid autoimmune disease and DTC seem not to affect basal serum CT levels in patients with thyroid nodules. Therefore, in the presence of hypercalcitoninemia, MTC should be routinely excluded also in
Search for other papers by Grigoris Effraimidis in
Google Scholar
PubMed
Search for other papers by Jan G.P. Tijssen in
Google Scholar
PubMed
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
Introduction Autoimmune thyroid disease (AITD) is a multifactorial condition and genetic factors as well as environmental factors are thought to play a role in its pathogenesis. Twin studies suggest that genetic factors account for about 70
Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Search for other papers by Susan C. Lindsey in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Alberto L. Machado in
Google Scholar
PubMed
Search for other papers by João Roberto M. Martins in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
Search for other papers by Magnus R. Dias da Silva in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by José Gilberto H. Vieira in
Google Scholar
PubMed
Fleury Medicine and Health, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
, such as autoimmune thyroid diseases (ATD) or chronic renal failure (CRF), the corresponding mild elevations in basal sCT result in indeterminate results regarding MTC diagnosis [ 14 , 15 ]. We developed a novel assay because the gold standard assay
UCLA School of Medicine, University of California, Los Angeles, California, USA
Search for other papers by Sandra M. McLachlan in
Google Scholar
PubMed
Search for other papers by Holly A. Aliesky in
Google Scholar
PubMed
Search for other papers by Priscilla Garcia in
Google Scholar
PubMed
Search for other papers by Bianca Banuelos in
Google Scholar
PubMed
UCLA School of Medicine, University of California, Los Angeles, California, USA
Search for other papers by Basil Rapoport in
Google Scholar
PubMed
that resemble autoantibodies in human autoimmune thyroid disease. J Clin Endocrinol Metab 1999; 84: 1651–1657. 30 Jaume JC, Rapoport B, McLachlan SM: Lack of female bias in a mouse model of autoimmune hyperthyroidism (Graves’ disease
Search for other papers by Anthony P. Weetman in
Google Scholar
PubMed
nature of the predisposing factors in autoimmune thyroid disease, and these will therefore form the basis of this review. But to start with, it is worth reminding ourselves of what Hashimoto described and how this fits historically into the general
Search for other papers by Yasmine Abdellaoui in
Google Scholar
PubMed
Search for other papers by Dimitra Magkou in
Google Scholar
PubMed
Search for other papers by Sofia Bakopoulou in
Google Scholar
PubMed
Search for other papers by Ramona Zaharia in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
What Is Known about This Topic? Both Graves’ disease and autoimmune hypothyroidism were described in patients with resistance to thyroid hormone beta (RTHβ). Undiagnosed RTHβ can lead to misdiagnosis of Graves’ disease. The
Search for other papers by Berglind Jonsdottir in
Google Scholar
PubMed
Search for other papers by Markus Lundgren in
Google Scholar
PubMed
Search for other papers by Sara Wallengren in
Google Scholar
PubMed
Search for other papers by Åke Lernmark in
Google Scholar
PubMed
Search for other papers by Ida Jönsson in
Google Scholar
PubMed
Search for other papers by Helena Elding Larsson in
Google Scholar
PubMed
(TGAb), and the TSH receptor [ 1 ]. Thyroid autoimmunity may cause cellular damage and result in autoimmune thyroid disease (AITD), with two opposing clinical phenotypes: autoimmune hypothyroidism and Graves’ hyperthyroidism. Autoimmune hypothyroidism